Methods of delivering therapeutic agents
Devices and methods of delivering therapeutic agents to tissue are provided, which provide reduced outflow of therapeutic agents from an injection site. The methods include delivering one or more clot-promoting substances, such as platelets, fibrin and/or thrombin, to the injection site to entrap the therapeutic agent in the injection site. Devices include devices that are suitable for use in the provided methods.
1. A method of delivering a therapeutic at a target site comprising:
inserting a catheter into the body of a patient;
guiding an end of the catheter towards a tissue target site within the body of the patient;
creating a channel in the target site with the catheter;
delivering a therapeutic contained in the catheter to the target site;
delivering platelets contained in the catheter to the target site wherein there is incremental clotting of the platelets; and
after delivering the therapeutic and platelets, removing the catheter from the target site, wherein the incremental clotting of the platelets prevents the leakage of the therapeutic from the target site after the catheter removal, and
wherein the platelets are delivered before, substantially simultaneously with or after the delivery of the therapeutic, and wherein the therapeutic is not carried by the platelets.
2. The method of claim 1 wherein the platelets were previously taken from the patient.
3. The method of claim 1 further comprising:
premixing the platelets and therapeutic prior to inserting the catheter into the body of the patient.
4. The method of claim 1 wherein the catheter contains a coated piercing tip, the coating reducing the adherence between a clot formed in the target site and the piercing tip.
5. The method of claim 1 further comprising:
separating platelets out of a patient's blood with a filtration system in the catheter.
6. The method of claim 1 wherein creating a channel in the target site with the catheter comprises:
inserting a piercing tip into the target site;
retaining the piercing tip in the target site for a predetermined period of time;
and removing the piercing tip from the target site.
7. The method of claim 3 , wherein the platelets were previously taken from the patient.
8. The method of claim 3 , wherein the catheter contains a coated piercing tip, the coating reducing the adherence between a clot formed in the target site and the piercing tip.
9. The method of claim 3 , further comprising separating platelets out of a patient's blood with a filtration system in the catheter.
10. The method of claim 3 , wherein creating a channel in the target site with the catheter comprises:
inserting a piercing tip into the target site;
retaining the piercing tip in the target site for a predetermined period of time;
and removing the piercing tip from the target site.
11. The method of claim 1 , further wherein the therapeutic is carried within a first lumen in the catheter and the platelets are carried within a second lumen in the catheter.
12. A method of delivering a therapeutic at a target site comprising:
inserting a catheter into the body of a patient;
guiding an end of the catheter towards a tissue target site within the body of the patient;
creating a channel in the target site with the catheter;
delivering a therapeutic contained in the catheter to the target site, wherein the therapeutic is carried by a plurality of platelets and wherein there is incremental clotting of the platelets; and
after delivering the therapeutic, removing the catheter from the target site,
wherein the incremental clotting of the platelets prevents the leakage of the therapeutic from the target site after the catheter removal.
13. The method of claim 12 , wherein the platelets were previously taken from the patient.
14. The method of claim 12 , wherein the therapeutic is released when the platelets rupture.
15. The method of claim 12 , wherein the platelets are artificial.
16. The method of claim 12 , wherein the catheter contains a coated piercing tip, the coating reducing the adherence between a clot formed in the target site and the piercing tip.
17. The method of claim 12 , further comprising separating platelets out of a patient's blood with a filtration system in the catheter.
18. The method of claim 12 , wherein creating a channel in the target site with the catheter comprises:
inserting a piercing tip into the target site;
retaining the piercing tip in the target site for a predetermined period of time;
and removing the piercing tip from the target site.
19. The method of claim 15 , wherein the artificial platelets are polymer beads.
20. The method of claim 12 , wherein the therapeutic is a pharmaceutically active compound, pharmaceutically active protein, pharmaceutically active polypeptide or pharmaceutically active liposome.